Theurey BioPharma ApS: Financial statements 2025
CVR: 44441594
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Theurey BioPharma ApS (CVR 44441594) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -85 and a net result of DKK -85. Equity in the 2025 report amounted to DKK 39,915. The solvency ratio was 100%.
- Gross Profit
- DKK -85
- Profit/Loss
- DKK -85
- Equity
- DKK 39,915
- Total Assets
- DKK 39,915
- Employees
- 0
Official annual report
How creditworthy is Theurey BioPharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Theurey BioPharma ApS has published its interim report for the period November 15, 2023 to December 31, 2024.
About Theurey BioPharma ApS
Theurey BioPharma ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2023. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Pierre Marie Christian Theurey. The company is owned by Pierre Marie Christian Theurey. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -85 and a net result of DKK -85. Equity in the 2025 report amounted to DKK 39,915.
